288 related articles for article (PubMed ID: 6395120)
21. [Calcium channel as molecular target of drug action].
Taglialatela M; Annunziato L; Marino A
Clin Ter; 1989 Dec; 131(5):299-305. PubMed ID: 2558001
[TBL] [Abstract][Full Text] [Related]
22. [Criteria for the evaluation of the therapeutic use of calcium antagonist drugs].
Mariani AR; Filippello CP; Iovene A; Paoletti V; Mammarella A
Clin Ter; 1987 Nov; 123(3):167-76. PubMed ID: 2972478
[No Abstract] [Full Text] [Related]
23. [Role of calcium antagonists in the treatment of cardiovascular diseases].
Akhmedkhanov SSh; Pomerantsev VP; Vasiuk IuA; Mdinaradze IuS
Sov Med; 1985; (3):44-51. PubMed ID: 3895459
[No Abstract] [Full Text] [Related]
24. [Calcium antagonists--their clinical use].
Draganov V
Vutr Boles; 1985; 24(2):29-36. PubMed ID: 3898584
[No Abstract] [Full Text] [Related]
25. [The role of calcium in striated cardiac and vascular smooth muscle cells].
D'Agostino F
Clin Ter; 1988 Feb; 124(4):303-13. PubMed ID: 2849522
[No Abstract] [Full Text] [Related]
26. Clinical pharmacology of calcium entry blockers.
Bianchi CP
Cardiovasc Clin; 1983; 14(1):123-8. PubMed ID: 6311420
[No Abstract] [Full Text] [Related]
27. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
28. [Calcium channel blockers. Review and attempt at classification].
van Zwieten PA; Timmermans PB
Rev Esp Cardiol; 1984; 37(5):322-9. PubMed ID: 6387828
[No Abstract] [Full Text] [Related]
29. [Criteria of the clinical application of Ca++ antagonists].
Kishida H; Saito H; Hayakawa H
Nihon Rinsho; 1982; 40(11):2477-83. PubMed ID: 6218317
[No Abstract] [Full Text] [Related]
30. [Calcium-blockers or calcium antagonists].
Chávez Rivera I
Arch Inst Cardiol Mex; 1982; 52(3):259-67. PubMed ID: 7052003
[No Abstract] [Full Text] [Related]
31. [Pharmacologic and therapeutic perspectives on calcium inhibitors].
Godfraind T
Bull Mem Acad R Med Belg; 1982; 137(12):737-53. PubMed ID: 6309312
[No Abstract] [Full Text] [Related]
32. Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.
Braun LT
Heart Lung; 1983 May; 12(3):226-32. PubMed ID: 6551368
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism of action of calcium antagonists].
Stimpel M; Neyses L
Schweiz Rundsch Med Prax; 1985 May; 74(19):483-90. PubMed ID: 2409579
[No Abstract] [Full Text] [Related]
34. A symposium: The calcium ion, cardiac myocyte and vascular smooth muscle in hypertension and its treatment. March 27-29, Nassau, the Bahamas.
Am J Cardiol; 1987 Jan; 59(2):1A-121A. PubMed ID: 2433924
[No Abstract] [Full Text] [Related]
35. Effects of calcium on vascular smooth muscle tone.
Morgan KG; Suematsu E
Am J Hypertens; 1990 Dec; 3(12 Pt 2):291S-298S. PubMed ID: 2078315
[TBL] [Abstract][Full Text] [Related]
36. [New approach to the development of Ca antagonists].
Baba A; Arita M; Masuyama Y
Nihon Rinsho; 1989 Aug; 47(8):1788-93. PubMed ID: 2585742
[No Abstract] [Full Text] [Related]
37. [Heart rate determination of oxygen consumption].
Heusch G
Fortschr Med; 1987 Dec; 105(35):74-5. PubMed ID: 3436610
[No Abstract] [Full Text] [Related]
38. [Dilzem - a new calcium antagonist is introduced].
Bohl E
ZFA (Stuttgart); 1982 Feb; 58(5):292-6. PubMed ID: 7080650
[No Abstract] [Full Text] [Related]
39. [Pharmacological aspects and therapeutic uses of verapamil and related calcium antagonists (author's transl)].
Penna M; Pescio S
Rev Med Chil; 1980 Oct; 108(10):924-30. PubMed ID: 7012975
[No Abstract] [Full Text] [Related]
40. [Pharmacological introduction to the clinical use of calcium antagonists].
Ferrari R; Boraso A; De Giuli F; Cargnoni A; Pasini E; Condorelli E; Boffa GM; Visioli O
G Ital Cardiol; 1988 Nov; 18(11):956-69. PubMed ID: 2854799
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
